53 results about "Chicken Pox" patented technology

A composition containing enhanced colloidal oatmeal which utilizes other avena sativa ingredients to neutralize the discomfort, irritation and inflammation of the skin, as well as maintaining normal skin, and can be used to treat many types of discomforts, including itching; due to poison ivy, oak and sumac, insect bites, sunburn, chicken pox, hives, prickly heat, chafing, and the like while maintaining the normal pH of the skin.

Jojoba alcohol, a mixture of long chain monounsaturated alcohols, is an oily liquid at moderate ambient temperatures. It is readily absorbed by human skin where it relieves irritation and inhibits the formation of lesions caused by viruses. The inhibitory action is applicable to enveloped viruses which express as sores at dermal surfaces in humans. When applied topically to an incipent herpes episode, it will quickly penetrate the epidermis to the subdermal vascular cells and suppress viral replication which leads to inflammation and the formation of blisters on the face, genital and other skin and mucosal areas. Fumaric acid and malonic acid at low concentrations also inhibit the replication of varicella zoster virus in human cell cultures, with no cellular toxicity. Compositions of certain low molecular weight organic acids in jojoba alcohol enhance antiviral activity. Topical treatment of shingles with a low concentration of fumaric acid in jojoba alcohol terminates the episode. This combination drug acts by a dual mechanism wherein the jojoba alcohol blocks viral fusion by a lipoidal mode, and the polycarboxylic acids inhibit viral fusion by an ionic mode. The combination drug can also be effective in treating chicken pox. Jojoba alcohol is a carrier and transdermal delivery system for these and other pharmacologically active agents for the relief of pain and treatment of other conditions which occur at or under the surface of the skin. Topically applied jojoba alcohol is non-toxic and safe for animals and humans.

The invention discloses a traditional Chinese medicine combination for curing visceral inflammation of human bodies. The raw materials which are prepared into the active components comprise melastoma dodecandrum lour, garden burnet, lobelia chinensis, honeysuckle, isatis root, rhizome anemarrhenae, Chinese thorowax root, pomegranate rind, plantain, Chinese caterpillar fungus, licorice root, Corsvenor momordica fruit, codonopsis, Chinese wolfberry, radix ginseng rubra and white ginseng. The combination has effect in invigorating the lung and reinforcing kidney, replenishing Qi and invigorating the spleen, greatly nourishing vital energy, cleaning heat, purging fire and removing toxins, generating saliva and moisturizing dryness, cooling blood and relieving sore throat, promoting urination and detumescence, moisturizing the lung, dredging the pulse vessel and removing fever, soothing the liver, and the like, has better functions of preventing and curing various visceral inflammations of human bodies, has particular efficacy to cure the diseases, like virus hepatitis, typhoid, nephritis and pneumonia and has certain effect in curing diseases, like swells in the loin, lumbodynia, diarrhea, hematochezia, dysentery, gonorrhea, diabetes, various types of gynecopathy, reddish swelling, chicken pox, cough, cold and fever.

The present invention provides a freeze-dried hepatitis-A-chicken-pox attenuation combined vaccine and a production thereof. The combined vaccine has the security and the immunogenicity as good as the univalent vaccine and can effectively prevent the hepatitis A and the chicken pox. Two kinds of diseases can be effectively prevented just by one immunization, which can reduce vaccine cost, improve vaccine inoculation efficiency and reduce the bad reaction caused by a plurality of times of injections, and can reduce the vaccine inoculation times but realize the purpose of preventing various diseases.

The invention discloses a ginseng cosmetic fancy soap, belonging to daily articles for cleaning. The ginseng cosmetic fancy soap is prepared by mixing a Chinese medicine composition and a soap base in the mass ratio of 1:1 and then pressing, wherein the Chinese medicine composition is prepared by pulverizing and mixing ginseng, fritillary bulb, ledebouriella seseloides, angelica root, chrysanthemum, moutan bark, common peony root, talcum powder and rhizoma typhonii powder. The ginseng cosmetic fancy soap can be used for treating diseases, such as acnes, flat warts, chloasma, freckles, xerosis cutis and crack and the like and can solve the problems of acne wound healing indolence, face itches due to wind blowing, rugged faces caused by scars due to healing of chicken pox and acnes and the like and is a real multipurpose cosmetic fancy soap.

The invention relates to a drug for treating chicken pox and a preparation method thereof, pertaining to the field of blood products. The technical problem solved by the invention is that: a drug which can effectively treat chicken pox is provided. The drug for treating chicken pox is a preparation which is prepared by adopting a chicken pox human immune globulin as a main active ingredient and adding with accessories acceptable in pharmacy, wherein, the chicken pox human immune globulin is prepared by adopting blood plasma obtained after a varicella vaccine is used for immunizing human bodies as raw material. The drug for treating chicken pox can be used for treating or preventing cytomegalovirus diseases and has wide application prospect.

The invention relates to a Chinese medicinal powder for treating fowl pox and process for preparation, which is prepared from the following constituents (by weight portions) through mixing homogeneously: bupleurum root 48-72g, honeysuckle flower 48-72g, capsule of weeping forsythia 36-54g, spearmint 24-36g. The preparing process consists of disintegrating the raw materials, passing through 20-80 mesh sieves, and mixing homogeneously.

The present invention relates to novel Varicella-zoster virus strain and to a chicken pox and herpes zoster virus vaccine using the same. More particularly, the present invention relates to genome DNA of VZV MAV / 06 strain isolated from a Korean patient, to an open reading frame (ORF) thereof, to a protein coded by the genome DNA of VZV MAV / 06 strain and the ORF thereof, and to a vaccine composition which contains the protein as an active ingredient.

There is provided a pharmaceutical drug, particularly a novel compound useful for prophylaxis or a therapeutic treatment of various diseases involving infections with viruses of the herpesvirus family, specifically various herpesvirus infections such as varicella (chicken pox) via varicella zoster virus, varicella zoster via recurrent infection with latent varicella zoster virus, herpes labialis and herpes encephalitis via HSV-1 and genital herpes via HSV-2 infection. An N-{2-[(4-substituted phenyl)amino]-2-oxoethyl}tetrahydro-2H-thiopyran-4-carboxamide derivative, of which phenyl group is substituted at position 4 with a specific 5- or 6-membered heteroaryl group, and a salt thereof have an effective anti-virus activity, and the oral administration thereof at a low dose enabled the therapeutic treatment of the above diseases.

The invention discloses a preparation method of a chicken pox virus antibody, belonging to the technical field of biology. The method comprises the following steps: (1) culturing the chicken pox virus, and preparing a coarse antigen; (2) preparing the concentrated and purified antigen; (3) preparing the animal immune and antiserum; and (4) purifying the antibody. The antibody prepared by the method disclosed by the invention has the advantages of high purity and favorable specificity, and can be widely used for preparing reagents for detecting chicken pox virus infection.

Disclosed is a recombined chicken pox virus vaccine rFPV-12LSH5H9, its construction method and use, wherein the construction process consists of placing AIV HA gene fragment containing H5 hypotype and H9 hypotype onto the downstream of right promotors, inserting into chicken poxviridae expression vector p12-18 containing FPV duplicated non-indispensable fragment FPV1-2 and reported genes through backside cascade connection to construct transition vector p12LSH5H9, then transforming chick embryo desmocyte infected with wt-FPV with the transition vector p12LSH5H9, and obtaining co-expression H5 and H9 hypotype AIV HA gene rFPV-12LSH5H9 through consanguinity recombination.

The present invention belongs to the field of biotechnology, and is especially one kind of recombinant live carrier vaccine co-expressing pig gyrate virus and foot and mouth disease virus. The present invention aims at providing two recombinant chicken pox viruses to co-express capsid protein ORF2 or its fusion protein ORF2-ORF1 of the China epidemic strain of type-II pig gyrate virus and the structural protein precursor P1 of the China epidemic strain NY00 of type-O foot and mouth disease virus, and for serving as the duplex live carrier gene engineering vaccine to prevent PCV2 and FMDV infection. The two recombinant chicken pox viruses can stimulate mouse to generate effective body fluid immunity and cell immunity, and are safe to experimental animals without any pathological phenomenon.

The invention discloses application of a Chinese medicine composition in the preparation of a medicament for treating chicken pox. The Chinese medicine composition comprises fructus forsythiae, honeysuckle, Chinese ephedra, bitter almond and the like. The Chinese medicine composition has wide antivirus function, and effectively treats chicken pox by effectively killing viruses, allaying fever anddiminishing inflammation.

The present invention relates to a heat-resisting freeze-dried protection agent for chicken pox freeze-dried vaccine and its preparation process. It is characterized by that its composition includes gelatin 3%, lactose 5-6%, EDTA 2%, PVP (K90) 5%, sorbitol 2%, sodium glutamate 1%, beef peptone 2%, bovine serum albumin 1% and Vc 0.1%, and the rest is distilled water. Said invention also provides its preparation method and concrete steps, and its application.

Disclosed is a recombined chicken pox virus vaccine rPFV-12LSH9A, preparation process and use, wherein the construction process consists of placing AIV HA gene fragment containing H9 hypotype onto the downstream of right promotors, inserting into chicken poxviridae expression vector p12-18 containing FPV duplicated non-indispensable fragment FPV1-2 and reported genes to construct transition vector, then transforming chick embryo desmocyte infected with wt-FPV with the transition vector, and obtaining rFPV expressing H9 hypotype AIV HA gene through consanguinity recombination, i.e. recombinant chicken poxviridae vaccine rFPV-12LSH9A.

The medicine for preventing and treating chicken pox is prepared with 13 kinds of Chinese medicinal materials including gromwell, buffalo horn, cimicifuga rhizome, cicada slough, isatis leaf, etc. in certain proportion, and through pulverizing, milling into fine powder and mixing. Before clinical using, the medicine is soaked in boiled water for 30-60 min for the effective components in the medicine to be leached out fully and for the sick chicken to absorb well, and small amount of sugar and vitamin C are added to raise the treating effect. The medicine has high clinical curative rate, no negative effect, no residue and no resistance.

The invention belongs to the technical field of preparation of antiserum of chicken pox, in particular relates to a preparation device for antiserum of chicken pox. The device comprises a bottom plate. The top end of the bottom plate is fixedly connected to a supporting rod, the top end of the supporting rod is fixedly connected to a workbin, a conveying pipe is fixedly connected to the inner sideof the workbin, a foam removal device is arranged on the inner side of the workbin, the bottom end of the workbin is fixedly connected to a connecting pipe, an unloading device is fixedly connected to the left side of the connecting pipe, the top end of the bottom plate is fixedly connected to a supporting plate, the top end of the supporting plate is fixedly connected to a striking gear, a circular conveying device is fixedly connected to the inner side of the supporting plate, the top end of the bottom plate is fixedly connected to a collecting box, and the collecting box is arranged rightbelow the right end of the circular conveying device. A foam removal thin pipe is pressed to drive a sealing pressure plate to move downward, material foam overflows first through the foam removal thin pipe, and then a foam receiving cup receives the material foam to remove the foam. The material foam floating on a material liquid level can be removed completely, so that the material effect is improved and the unloading effect is guaranteed.

The invention relates to a novel ointment for treating a microorganism infection skin disease and a preparation process thereof. The novel ointment for treating the microorganism infection skin disease consists of the following materials in part by mass: 0.1 to 0.3 part of trivalent silver ion compound, 0.2 to 0.4 part of keratinase, 0.5 to 5 parts of water-soluble keratin, 2 to 3 parts of composite vitamin and 94.3 to 98.7 parts of white petroleum jelly. The preparation process particularly comprises the following steps of: grinding 0.1 to 0.3 part of trivalent silver ion compound, 0.2 to 0.4 part of keratinase, 0.5 to 5 parts of water-soluble keratin and 2 to 3 parts of composite vitamin into powder; and adding 94.3 to 98.7 parts of white petroleum jelly into the powder and uniformly mixing the mixture. The ointment has the effects of rapidly sterilizing and relieving itching, expelling toxin and removing rot, and repairing skin. The ointment is suitable for treating and protecting a local skin disease caused by microorganism infection, such as fugal infection of hand and foot, tinea corporis, tinea cruris and onychomycosis (ringworm of the nails) caused by fungi, erysipelas and leprosy caused by bacteria, chicken pox, flat wart and herpes caused by virus and the like.

The invention discloses a Chinese herbal medicine for treating chicken pox. The Chinese herbal medicine is prepared from the following medicines in parts by weight: 5-15 parts of fineleaf schizonepeta herb, 5-15 parts of divaricate saposhnikovia root, 5-15 parts of Szechuan lovage rhizome, 6-12 parts of sinkiang arnebia root peel, 4-12 parts of cicada shell, 5-10 parts of coptis root, 5-10 parts of baikal skullcap root, 5-10 parts of amur corktree bark, 6-15 parts of skunk bugbane, 5-15 parts of common lophatherum herb and 5-15 parts of honeysuckle stem. The Chinese herbal medicine is prepared by carrying out the following steps: adding 1200 parts of water; boiling, and decocting with soft fire for 20-30 minutes; collecting supernatant by filtering; decocting for three times, and mixing supernatant decocted in the three times; bottling, and sterilizing at high temperature for later use. The fineleaf schizonepeta herb is taken as a monarch; the divaricate saposhnikovia root and the Szechuan lovage rhizome are taken as ministers; the sinkiang arnebia root peel, the cicada shell, the coptis root and the baikal skullcap root are taken as assistants; the amur corktree bark, the skunk bugbane, the common lophatherum herb and the honeysuckle stem are taken as guides. The Chinese herbal medicine composition for treating chicken pox has a good effect, is safe and free from side effects, convenient to take and low in production cost, and is an ideal medicament for treating chicken pox by clearing away heat and toxic materials.

The embodiment of the invention discloses a medicine for disinfecting and rash removal. The medicine comprises, by weight, 20% of Chinese herbaceous peony, 20% of the root of kudzu vine, 10% of rdix ohiopogonis, 15% of rattletop, 15% of rhizoma zingiberis and 10% of liquorice seeds. The medicine is used in the initial stage of hot dermexanthesis diseases or used for a patient with meningeal irritation symptoms caused by headaches caused by flu. The medicine is used for treating the flu, measles, scarflet fever, chicken pox, epistaxis, eyeball congestion, tonsillitis and the like.

The invention provides a traditional Chinese medicinal preparation. The preparation is prepared from the following components by weight: 10g of apricot kernel, 6g of amomum cardamomum, 20g of coix seed, 10g of raw liquorice, 15g of poria, 15g of honeysuckle, 15g of fructus forsythiae and 10g of cicada slough. The preparation has the effects of clearing heat and removing toxicity, dispelling wind heat, cooling blood and dissolving purpura, and the like due to compatibility of the medicinal materials, has a remarkable curative effect for treating chicken pox, and has the advantages of quick curative effect, short course of treatment, high cure rate, relapse prevention, no toxic or side effect and no adverse response.

The invention relates to an infant health care product and a preparation and usage method thereof, and in particular provides a health care product special for infant bat and a preparation method thereof. The product has good curative effects on sensitive skin with drying, peeling, swelling, itching, burns, eczema, and chicken pox, improves blood circulation and makes the skin more smooth and comfortable. The product is supported by oat flour and a combined oil for usage.

The invention discloses a method for culturing a chicken pox-herpes zoster vaccine virus with a high-level human diploid cell. The method comprises the steps of establishing a main cell bank: taking an ATCC (American Type Culture Collection) (CCL171) cell strains at a 17th generation at the beginning according to United States FDA (Food and Drug Administration) standards, subculturing for totally 3-5 times in approximately 20 days, storing collected cells in liquid nitrogen with a cryovial, conducting working cell bank cell culture, horizontally synchronously monitoring diploid cell population doubling, and producing a vaccine with the cell strains having diploid cell population doubling levels above 2.5. With the adoption of the method, the yield of the attenuated chicken pox-herpes zoster virus vaccine is higher, and the method facilitates large-scale preparation of the herpes zoster vaccine and is applicable to scale production. The method can be used for industrial production of other live vaccines such as a hepatitis A vaccine, a rabies vaccine, a measles vaccine and a smallpox vaccine.

The invention provides a medicine for treating chicken pox in children. The medicine is characterized by being prepared from the following components in parts by weight: 10-20 parts of radix isatidis, 10-15 parts of fructus forsythiae, 10-15 parts of semen plantaginis, 10-12 parts of scutellaria baicalensis, 10-15 parts of moutan bark, 10-12 parts of Chinese violet, 5-6 parts of gypsum, 10-12 parts of radix scrophulariae, 10-12 parts of rhizoma alismatis, 10-12 parts of peppermint, 10-12 parts of schizonepeta, 10-12 parts of rhizoma anemarrhenae, 10-12 parts of burdock, 10-12 parts of rhizoma cimicifugae, 10-12 parts of kudzu vine root, 10-12 parts of cornu bubali, 10-12 parts of moutan bark and 5-8 parts of licorice root. The medicine has the advantages of use of easily available raw materials, low cost, remarkable treatment effect and the like.

The present invention describes a composition for preventing pruritis or inflammation that includes field pussy-toes plant extract, and methods of using and manufacturing the same. The compositions of this invention have been found to be especially useful in preventing and treating lesions from poison ivy, chicken pox, and cold sores.

The invention belongs to the technical field of traditional Chinese medicine cores and particularly relates to a scent bag medicine core capable of preventing infectious diseases. The scent bag medicine core capable of preventing infectious diseases mainly solves the technical problem that an existing infectious disease treatment method brings large mental and economic burdens to patients. According to the technical scheme, the scent bag medicine core capable of preventing infectious diseases is prepared from, by weight, 10-15 parts of honeysuckle, 6-12 parts of wrinkled giant hyssop, 6-12 parts of eupatorium, 5-10 parts of cloves, 6-12 parts of cyrtomium fortunei, 6-10 parts of folium artemisiae argyi, 6-10 parts of amomum tsaoko, 5-10 parts of amomum cardamomum, 5-10 parts of fructus amomi, 10-15 parts of acorus gramineus, 10-15 parts of polygala tenuifolia, 5 parts of cinnamon, 3 parts of borneol and 6-10 parts of evodia rutaecarpa. The scent bag medicine core has a very good curative effect on preventing and treating respiratory system infectious diseases, flu, hand, foot and mouth diseases, mumps, chicken pox, bird flux and the like and will not bring large mental and economic burdens to patients.

The invention discloses a traditional Chinese medicine oral liquid for treating chicken pox, which comprises 13-17g of herba houttuyniae, 8-12g of gromwell, 8-12g of Rabdosia rubescens, 8-12g of gynostemma pentaphyllum, 8-12g of safflower seed, 8-12g of radix astragali, 8-12g of Isatis indigotica Fort, 3-7g of mockstrawberry, 3-7g of honeysuckle flower, 3-7g of belamcanda rhizome, 3-7g of Fructus Forsythiae and 3-7g of hay. The preparation technique comprises the following steps: (1) sorting; (2) superfine grinding; (3) soaking; (4) liquor extraction; (5) microwave extraction; (6) filtering; (7) preservative addition; and (8) packaging. The traditional Chinese medicine oral liquid disclosed by the invention has the advantages of favorable effect for treating chicken pox, low residue and high biosafety, and is convenient to use.